106 related articles for article (PubMed ID: 461952)
1. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay.
Monji N; Castro A
Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952
[TBL] [Abstract][Full Text] [Related]
2. Disposition of nicotine in the rat after intravenous administration.
Adir J; Miller RP; Rotenberg KS
Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):173-83. PubMed ID: 1257606
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
4. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat.
Miller RP; Rotenberg KS; Adir J
Drug Metab Dispos; 1977; 5(5):436-43. PubMed ID: 20291
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
[TBL] [Abstract][Full Text] [Related]
6. Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animals.
Düsterberg B; Kühne G; Täuber U
Arzneimittelforschung; 1986 Aug; 36(8):1187-90. PubMed ID: 3778555
[TBL] [Abstract][Full Text] [Related]
7. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
Ochs HR; Smith TW
J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
Klotz U; Antonin KH; Bieck PR
J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
Timchalk C; Nolan RJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
[TBL] [Abstract][Full Text] [Related]
10. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
Krotscheck U; Boothe DM; Little AA
Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog.
Dixon R; Carbone JJ; Mohacsi E; Perry C
Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):243-55. PubMed ID: 734214
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of pidotimod in rats and dogs.
Coppi G; Silingardi S
Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous and intramuscular methohexitone in dogs.
Pinaud M; Meignier M; Kergueris MF; Le Normand Y; Lasserre MP; Souron R; Larousse C
Eur J Anaesthesiol; 1984 Mar; 1(1):55-62. PubMed ID: 6536507
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and pharmacodynamics of sulfinalol hydrochloride in dogs after intravenous administration.
Park GB; Koss RF; DeFelice AF; O'Neil SK; Edelson J
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):4-13. PubMed ID: 6129834
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of diltiazem. Distribution, excretion and protein binding in rat and dog.
Nakamura S; Suzuki T; Sugawara Y; Usuki S; Ito Y; Kume T; Yoshikawa M; Endo H; Ohashi M; Harigaya S
Arzneimittelforschung; 1987 Nov; 37(11):1244-52. PubMed ID: 3440032
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of thiamphenicol in dogs.
Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
[TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
20. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
